Emil D Kakkis
Director, President & CEO · 2 filings · Latest: Apr 16, 2026
Ultragenyx Pharmaceutical Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RARE | Emil D Kakkis | Director, President & CEO | Mar 2, 2026 | Sale | $22.80 | 54,404 | $1.2M | 658,994 | |
RARE | KAKKIS EMIL D | — | Feb 28, 2025 | Proposed Sale | $42.48 | 25,000 | $1.1M | — | |
RARE | KAKKIS EMIL D | — | Dec 30, 2024 | Proposed Sale | $42.23 | 11,727 | $495.3K | — | |
RARE | KAKKIS EMIL D | — | Dec 10, 2024 | Proposed Sale | $50.00 | 8,273 | $413.6K | — | |
RARE | KAKKIS EMIL D | — | Sep 3, 2024 | Proposed Sale | $55.85 | 20,000 | $1.1M | — |